- PROFESSOR | Radiology
- PROFESSOR | Medicine
- Body Imaging
- Hospital Affiliations
- Mount Sinai Queens
- The Mount Sinai Hospital
- Radiology Associates 212-241-2642212-241-2642
Bachir Taouli, MD, MS, is Professor of Radiology and Medicine in the Body Imaging Section (Department of Radiology) and the Translational and Molecular Imaging Institute (TMII) at the Icahn School of Medicine at Mount Sinai, New York. After completing medical school and Radiology Residency in Paris VI University (France) in 2000, he joined the UCSF Department of Radiology for a research fellowship and post-doctoral clinical training. He then joined the NYU Department of Radiology where he worked for 6 years and where he developed clinical applications of advanced MRI techniques applied to liver, kidney and prostate diseases, including diffusion and perfusion imaging and spectroscopy. He joined the Icahn School of Medicine at Mount Sinai in 2009, where he is currently the director of Body MRI and Cancer Imaging in the Department of Radiology and TMII. Dr Taouli has been named vice-chair for translational research in April 2017. Dr. Taouli is a clinician scientist with particular expertise in the application of advanced MRI sequences applied to diffuse liver disease/liver cancer and abdominal and pelvic malignancies, including prostate cancer. He directs the Body MRI quantitative group at TMII (https://tmii.mssm.edu/research/research-laboratories/taouli-lab/). Dr. Taouli has extensive experience in Body MRI, and has been successfully NIH funded since 2010. He has authored/co-authored over 164 peer-reviewed manuscripts and book chapters primarily on body MRI, and lectured throughout the world on advanced body MRI techniques. Finally, Dr Taouli is a member of several scientific societies, including the Radiological Society of North America (RSNA), the International Society of Magnetic Resonance in Medicine (ISMRM), the American Roentgen Ray Society (ARRS), the Society of Abdominal Radiology (SAR), the European Society of Radiology (ESR), the American Association for the Study of Liver Diseases (AASLD), and the European Society of Gastrointestinal and Abdominal Radiology (ESGAR). He is a previous Associate editor for the American Journal of Roentgenology, previous member of the Annual Meeting Program Committee of the ISMRM, and the RSNA Gastrointestinal Radiology Subcommittee.
- CT Scan Of The Abdomen
- Diagnostic Ultrasound Of The Abdomen
- Inflammatory Bowel Disease
- Magnetic Resonance Imaging
- Upper Gastrointestinal Series
Cancer, Eye Movements, Liver, Magnetic Resonance Imaging, Mathematical Modeling of Biomedical Systems
Multi-Disciplinary Training Area
Biophysics and Systems Pharmacology [BSP]
MD, Universite D' Alger
Universite D' Alger
Residency, Diagnostic Imaging
Paris VI University (France)
University of California - San Francisco
Magna Cum Laude Merit Award for abstract
Quantitative IVIM-DWI and DCE-MRI for assessment of bowel inflammation in Crohn’s disease” (presented by S. Hectors
Magna Cum Laude Merit Award for abstract
“Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging” (presented by S. Hectors)
Best Translational Research/Dose Scientific Paper Award for abstract
Society of Abdominal Radiology,
“Quantification of hepatocellular carcinoma heterogeneity with multiparametric MRI”
J Magn Reson Imaging
Academy of Radiology Research
Summa Cum Laude Merit Award
Highly Accelerated 4D Flow using Spiral Sampling and Dynamic Compressed Sensing for Quantification of Flow in Abdominal Vessels
Radiology Society North America
Fellow of the Society of Abdominal Radiology
Best Paper-First time presenter
(Perfusion-weighted MRI of the Liver: Effect of T1 mapping on Perfusion Parameter Values and Parameter Reproducibility)
J Magn Reson Imaging
Magna Cum Laude Merit Award
Liver Fat Quantification with MRI: Comparison of 2 point-Dixon and 3 point-Dixon methods to T2 corrected multiecho single-voxel spectroscopy
10th International Symposium on High Field MRI
University of Bonn, Germany
Society of Uroradiology
Prostate cancer treated with radiation therapy: evaluation of response with advanced MRI techniques
Radiological Society of North America
Perfusion MRI and BOLD MRI for quantification of perfusion and oxygenation in HCC
Society of Gastrointestinal Radiologists
Diffusion-weighted MRI for diagnosis of liver fibrosis
Assessment of liver cancer with advanced MRI methods
Primary liver cancer (hepatocellular carcinoma: HCC) can be treated aggressively when diagnosed early, using for example hepatic resection of transplantation. Imaging plays a pivotal role in the detection of hepatocellular carcinoma. MRI is especially attractive as it is radiation free and can be easily repeated in patients with liver disease on a regular basis. One of Dr Taouli's research interests is to characterize liver tumors in terms of aggressiveness, angiogenesis and oxygen delivery through the use of advanced MRI methods.
Assessment of prostate cancer with MRI
MRI is the primary modality used for prostate cancer detection and staging. One of Dr Taouli's research interests is the use of multiparametric MRI to better detect and stage prostate cancer, and assess and predict response to radiation therapy.
Non invasive detection of liver fibrosis and cirrhosis with MRI
MRI is a versatile technique, with no radiation exposure, and the possibility of performing multiparametric imaging. One of the interesting applications of MRI is the non invasive detection of liver damage caused by hepatitis and other insults, usually assessed with liver biopsy. Dr Taouli's experience using diffusion and perfusion MRI showed potential usefulness for detection of liver fibrosis and cirrhosis. MR elastography is also an emerging technique that will soon be offered routinely to patients with liver disease at Mount Sinai.
Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?. AJR. American journal of roentgenology 2011 May; 196(5).
Chandarana H, Lee VS, Hecht E, Taouli B, Sigmund EE, Taouli B. Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience. Investigative radiology 2011 May; 46(5).
Rosenkrantz AB, Oei M, Babb JS, Niver BE, Taouli B. Diffusion-weighted imaging of the abdomen at 3.0 Tesla: image quality and apparent diffusion coefficient reproducibility compared with 1.5 Tesla. Journal of magnetic resonance imaging : JMRI 2011 Jan; 33(1).
Do RK, Chandarana H, Chandanara H, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B. Diagnosis of liver fibrosis and cirrhosis with diffusion-weighted imaging: value of normalized apparent diffusion coefficient using the spleen as reference organ. AJR. American journal of roentgenology 2010 Sep; 195(3).
Merkle EM, Szklaruk J, Taouli B, Felker E, Hajdu CH, Babb JS, Kim D, Taouli B. Imaging techniques in the diagnosis of hepatocellular carcinoma and metastatic carcinoma as a result of colon cancer. Gastroenterology & hepatology 2010 Aug; 6(8).
Marien T, Taouli B, Telegrafi S, Babb J, Lepor H. Optimizing the detection of subclinical inguinal hernias in men undergoing open radical retropubic prostatectomy. BJU international 2010 Nov; 106(10).
Lim RP, Tuvia K, Hajdu CH, Losada M, Gupta R, Parikh T, Babb JS, Taouli B. Quantification of hepatic iron deposition in patients with liver disease: comparison of chemical shift imaging with single-echo T2*-weighted imaging. AJR. American journal of roentgenology 2010 May; 194(5).
Rosenkrantz AB, Kopec M, Kong X, Melamed J, Dakwar G, Babb JS, Taouli B, Taouli B. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. Journal of magnetic resonance imaging : JMRI 2010 Jun; 31(6).
Rosenkrantz AB, Neil J, Kong X, Melamed J, Babb JS, Taneja S, Taouli B. Prostate Cancer: Comparison of 3D T2-weighted sequence (SPACE) with conventional 2D T2-weighted imaging for Image Quality and Tumor Detection. AJR Am J Roentgenol 2010; In press.
Chandarana H, Robinson E, Hajdu CH, Drozhinin L, Babb JS, Taouli B, Taouli B. Microvascular invasion in hepatocellular carcinoma: is it predictable with pretransplant MRI?. AJR. American journal of roentgenology 2011 May; 196(5).
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Taouli during 2016 and/or 2017. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Bayer HealthCare Pharmaceuticals / Onyx Pharmaceuticals Partnership
Scientific Advisory Board:
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.